However, it is unclear whether these apparently unaffected SMARCB1 PV carriers had clinical signs of SMARCB1-related SWN since they were not investigated by MRI, especially later in life, in order to exclude the occurrence of asymptomatic schwannomas. Here, SMARCB1 is linked to schwannoma.